Vision Expo 2023 – Stand 3

Vitamin B3 in Glaucoma Study

About our research

Vitamin B3 in Glaucoma Study is a multicentre placebo-controlled clinical trial looking at whether taking vitamin B3 (nicotinamide) can help protect nerve cells in glaucoma and slow down vision loss over two years. This is a global collaborative effort that will help us answer the question as to whether nicotinamide should be incorporated into clinical care for people with glaucoma.

What you’ll see

Learn more about nicotinamide – what we know so far, how it may be protective in glaucoma and where our current study is going.

Talk to us about

  • Healthy ageing and glaucoma.
  • How vitamin B3 works in the eye.
  • Joining the study if you have glaucoma (we’re currently recruiting!).

Who you’ll meet